awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38221152-28E72B64-ED4E-4BFE-B0F7-39D98356050D
Q38221152-28E72B64-ED4E-4BFE-B0F7-39D98356050D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38221152-28E72B64-ED4E-4BFE-B0F7-39D98356050D
Novel developments in the use of antimetabolites.
P2860
Q38221152-28E72B64-ED4E-4BFE-B0F7-39D98356050D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38221152-28E72B64-ED4E-4BFE-B0F7-39D98356050D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b42a8fc5e86df561c7221b910daeaeee5dc7663d
P2860
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy.